More recent but solid compilation of writing - https://www.fairobserver.com/
144 karma · joined August 28, 2012
Whether or not our model changes in the future remains to be determined, however, as Dave mentions in his next comment the long timeframe tech risks inherent to investing in many early stage biotechs present some unique challenges to a YC model in biotech.
One thing we have in our favor for Biotech Pulse is the baseline community of 19 early stage companies and their teams here at Harlem Biospace. We are hoping since this community already exists in the shared space that this will be a strong seed for the online community to grow from.
Thanks to maccman for a great platform to build on